Designed Minibinders Rewire Receptor Signaling to Enable Functional Human Myogenic Reprogramming
This study demonstrates that AI-designed synthetic protein minibinders (C6-DPC) can overcome signaling barriers to enable efficient, functional human myogenic reprogramming by simultaneously activating pro-myogenic FGFR pathways and suppressing anti-myogenic ALK1/TGFBR2 and inflammatory gp130 signals, thereby generating high-force muscle tissues from fibroblasts.